On June 11, 2019, Madame Jiao Hong, Commissioner of the National Medical Products Administration (NMPA), attended the first Global Health Forum of the Boao Forum for Asia held in the city of Qingdao. She delivered a speech at the event, and commented that China, as a key player in the global medical supply chain, is providing a large quantity of quality medical products to the global markets. The NMPA, a dedicated upholder of public health, safeguards drug safety, promotes innovation, enhances regulatory capacity, and advances global cooperation. It is the mission of NMPA to ensure drug safety and effectiveness, and make contributions to global health.  

During the meeting, Jiao met with Deputy Director-General of the World Health Organization (WHO) Dr. Zsuzsanna Jakab and CEO of the Global Alliance for Vaccines and Immunization (GAVI) Dr. Seth Berkeley. They discussed issues on the vaccine regulatory system, drug and vaccine pre-qualification, and development of innovative vaccine products. During her meeting with Dr. Jakab, Jiao said that the NMPA has enjoyed a productive partnership with the WHO in areas such as establishing a long-term mechanism for vaccine regulation, as well as protecting and promoting global health. China's vaccine regulatory system has passed two WHO assessments, and is currently preparing for a third assessment with higher standards than the previous ones. This process not only strengthens China's vaccine regulatory capacity, but also promotes the overall development of the vaccine industry in China. Dr. Jakab said that China, as a significant participant in the global public health system, plays an important role in realizing WHO's goal of universal health coverage by enhancing its vaccine manufacturing and regulatory capacity. Dr. Jakab reaffirmed WHO's full support in facilitating China's efforts in this regard.

In her meeting with Dr. Berkeley, Jiao mentioned that China is in the process of formulating the Vaccine Administration Law, which aims to comprehensively enhance regulation covering the whole-chain of the vaccine industry, from R&D, production and distribution to end use, in order to ensure vaccine quality and continued progress of the vaccine industry. Dr. Berkeley said that GAVI looks forward to enhancing cooperation with China to facilitate pre-qualification for more Chinese vaccine manufacturers, so that China-made vaccine products, which are safe, effective, and with controllable quality, will gain access to the global markets and contribute to public health in China and the world.

The Forum, with the vision of "Health beyond Health – In the Year of Sustainable Development 2030" and the theme of "Health for All", hosted talks on 3 topics: universal healthcare coverage, health in all policies and innovation. The event was attended by over 2600 experts, entrepreneurs, and officials from more than 55 countries and regions and international organizations, including the WHO, GAVI, and the World Intellectual Property Organization. It was chaired by Dr. Margaret Chan, Honorary Director-General of the WHO.